Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 876-882, July 1995

Insulin-resistant glucose metabolism in patients with microvascular angina—syndrome X

  • H. Vestergaard

      Affiliations

    • Corresponding Author InformationAddress reprint requests to H. Vestergaard, MD, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
  • ,
  • P. Skøtt

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
  • ,
  • R. Steffensen

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
  • ,
  • H. Wroblewski

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
  • ,
  • O. Pedersen

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
  • ,
  • J. Kastrup

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark

Received 30 March 1994; accepted 12 October 1994.

Abstract 

Studies in patients with microvascular angina (MA) or the cardiologic syndrome X have shown a hyperinsulinemic response to an oral glucose challenge, suggesting insulin resistance and a role for increased serum insulin in coronary microvascular dysfunction. The aim of the present study was to examine whether patients with MA are insulin-resistant. Nine patients with MA and seven control subjects were studied. All were sedentary and glucose-tolerant. Coronary arteriography was normal in all participants, and exercise-induced coronary ischemia was demonstrated in all MA patients. A euglycemic, hyperinsulinemic clamp was performed in combination with indirect calorimetry. Biopsy of vastus lateralis muscle was taken in the basal state and after 4 hours of euglycemia and hyperinsulinemia (2 mU · kg−1 · min−1). The fasting level of “true” serum insulin was significantly higher (43 ± 6 v 22 ± 3 pmol/L, P < .02) and the rate of insulin-stimulated glucose disposal to peripheral tissues was lower in patients with MA (13.4 ± 1.0 v 18.2 ± 1.4 mg · kg fat-free mass [FFM]−1 · min−1, P < .02) due to a decrease in nonoxidative glucose metabolism (8.4 ± 0.9 v 12.5 ± 1.3 mg · kg FFM−1 · min−1, P < .02). No difference was found in glucose or lipid oxidation rates between the two groups. In patients with MA, as well as in the pooled group of all participants, a positive correlation was demonstrated between the insulin-stimulated increment in fractional activity of skeletal muscle glycogen synthase (GS) and the increment in nonoxidative glucose metabolism after in vivo insulin exposure (MA: r = .73, P = .03; all participants: r = .73, P = .005), indicating a reduced in vivo activation of GS in MA patients. In conclusion, (1) MA is part of the insulin resistance syndrome, and (2) the insulin resistance is predominantly localized to the glycogen synthesis pathway in skeletal muscle tissue.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from the Danish Diabetes Association, Frimodt-Heiniken Foundation, Poul and Erna Sehsted Hansen Foundation, and Director Jacob Madsen and Olga Madsen Foundation, Denmark.

PII: 0026-0495(95)90240-6

Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 876-882, July 1995